Stock ATANA ATTANA AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Attana AB

Equities

ATANA

SE0010547273

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 23:00:00 19/05/2024 BST 		5-day change 1st Jan Change
0.102 SEK +3.03% Intraday chart for Attana AB +29.11% +3.03%
04-30 BioInvent Announces Evaluating Attana Technology CI
04-25 Attana AB Enters Third Year of A Five-Year Service and Support Contract with A Leading Health Institute in the US CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioInvent evaluating Attana Technology
AQ
BioInvent Announces Evaluating Attana Technology
CI
Attana enters the third year of a five-year service and support contract with a leading health institute in the US
AQ
Attana AB Enters Third Year of A Five-Year Service and Support Contract with A Leading Health Institute in the US
CI
New paper using Attana tecnology to understand how viruses enter human cells
AQ
One of US leading health institutes has placed an order for an upgrade of an existing instrument, valued at $150k
AQ
Attana AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
New paper using Attana Technology to study structures on surface in Ion Liquids demonstrating the effect of surface charges on interaction properties.
AQ
New publication using Attana technology towards environmentally friendly and financially viable methods to create functional materials
AQ
New article using Attana's technology from National University of Singapore: Immunity differences in vaccinated individuals according to age, gender, lifestyle and other diseases
AQ
Biosensors to characterize immune response to bacterial diseases
AQ
Attana and Linnaeus University have published the first part of the science behind immunity profiles
AQ
Attana Lands Order for Kinetic Interaction Analysis of Tissue in US
MT
Breakthrough order with new customer in the USA
AQ
Attana AB Receives Breakthrough Order with New Customer in the USA
CI
Strengthened collaboration with European biotech customer who extends their service and support agreement for another 12 months.
AQ
Customer Develops Therapeutic Antibodies Against Cancer and Uses Attana's Cell-Based Technology
CI
A new publication using Attana Technology from National University of Singapore examining the neutralization capacity of human IgG antibodies agsinst different mutations of the SARS-CoV-2
AQ
Robust QCM-Based Sensing and Assay Formats in Commercialized Systems
AQ
Attana AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATANA Stock
  4. News Attana AB